Literature DB >> 19110740

Scarring and persistent erythema after fractionated ablative CO2 laser resurfacing.

Risa Behar Ross1, James Spencer.   

Abstract

The adverse affects of traditional CO2 laser resurfacing have been well reported including scarring and hypopigmentation. With the advent of new technology, continuous research and development of new devices are being conducted to minimize these side effects, yet provide substantial results. The fractionated CO2 laser is a recently available product. The authors encountered a case of a 55-year-old female who presented 9 days posttreatment with a fractionated ablative CO2 laser resurfacing with similar side effects as seen with traditional ablative CO2 laser resurfacing.

Entities:  

Mesh:

Year:  2008        PMID: 19110740

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  5 in total

Review 1.  [Keloid and hypertrophic scar treatment modalities. An update].

Authors:  L K Branski; H O Rennekampff; P M Vogt
Journal:  Chirurg       Date:  2012-09       Impact factor: 0.955

2.  Fractional CO2 Laser Resurfacing Complications.

Authors:  William M Ramsdell
Journal:  Semin Plast Surg       Date:  2012-08       Impact factor: 2.314

3.  Treatment of post-burn and post-traumatic atrophic scars with fractional CO2 laser: experience at a tertiary care centre.

Authors:  Abid Keen; Gousia Sheikh; Iffat Hassan; Yasmeen Jabeen; Shagufta Rather; Syed Mubashir; Insha Latif; Sumaya Zeerak; Muzafar Ahmad; Aqib Hassan; Peerzada Ashraf; Faizan Younis; Najamul Saqib
Journal:  Lasers Med Sci       Date:  2018-02-23       Impact factor: 3.161

4.  Skin renewal activity of non-thermal plasma through the activation of β-catenin in keratinocytes.

Authors:  J H Choi; Y S Song; K Song; H J Lee; J W Hong; G C Kim
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

5.  The Clinical Effects of Pixel CO2 Laser on Bladder Neck and Stress Urinary Incontinence.

Authors:  Cheng-Yu Long; Jennifer Po-Ning Lee; Zi-Xi Loo; Yi-Yin Liu; Chang-Lin Yeh; Chien-Wei Feng; Kun-Ling Lin
Journal:  J Clin Med       Date:  2022-08-24       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.